Circulating cells: the biofactory for markers of atherosclerotic disease
Open Access
- 30 May 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 29 (22) , 2701-2702
Abstract
Atherosclerotic cardiovascular disease remains the number one killer of the ageing population in Western society. The natural history of the disease is unknown, and clinical events may strike without any warning. There have long been efforts to discover new biomarkers and to validate surrogate end-points to diagnose patients at risk for acute manifestations of atherosclerotic disease and to test treatment efficacy.Keywords
This publication has 9 references indexed in Scilit:
- Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndromeEuropean Heart Journal, 2008
- EPA and DHA in blood cell membranes from acute coronary syndrome patients and controlsAtherosclerosis, 2008
- Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserveHeart, 2007
- Total Cholesterol Content of Erythrocyte Membranes Is Increased in Patients With Acute Coronary SyndromeJACC, 2007
- Endurance training restores peritoneal macrophage function in post-MI congestive heart failure ratsJournal of Applied Physiology, 2007
- Intraplaque Hemorrhage and Progression of Coronary AtheromaNew England Journal of Medicine, 2003
- Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formationHeart, 2002
- Enhanced Response of Blood Monocytes to In Vitro Lipopolysaccharide-Challenge in Patients With Recurrent Unstable AnginaCirculation, 2001
- Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytesHeart, 1997